Rallybio (RLYB) Earnings Date & Reports

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RLYB is expected to report earnings to rise 20.62% to -25 cents per share on August 06

Q2'25

Est.

$-0.25

Q1'25

Beat

by $0.07

Q4'24

Beat

by $0.55

Q3'24

Beat

by $0.09

Q2'24

Missed

by $0.30

The last earnings report on May 08 showed earnings per share of -20 cents, beating the estimate of -28 cents. With 48.44K shares outstanding, the current market capitalization sits at 12.40M.

View a ticker or compare two or three

Compare

RLYB